Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jul 27;7(7):CD010783.
doi: 10.1002/14651858.CD010783.pub3.

Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)

Ingrid Arevalo-Rodriguez  1 , Nadja Smailagic  2 , Marta Roqué-Figuls  3 , Agustín Ciapponi  4 , Erick Sanchez-Perez  5 , Antri Giannakou  6 , Olga L Pedraza  5 , Xavier Bonfill Cosp  7 , Sarah Cullum  8
Affiliations
Meta-Analysis

Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)

Ingrid Arevalo-Rodriguez et al. Cochrane Database Syst Rev. .

Abstract

Background: Dementia is a progressive global cognitive impairment syndrome. In 2010, more than 35 million people worldwide were estimated to be living with dementia. Some people with mild cognitive impairment (MCI) will progress to dementia but others remain stable or recover full function. There is great interest in finding good predictors of dementia in people with MCI. The Mini-Mental State Examination (MMSE) is the best-known and the most often used short screening tool for providing an overall measure of cognitive impairment in clinical, research and community settings.

Objectives: To determine the accuracy of the Mini Mental State Examination for the early detection of dementia in people with mild cognitive impairment SEARCH METHODS: We searched ALOIS (Cochrane Dementia and Cognitive Improvement Specialized Register of diagnostic and intervention studies (inception to May 2014); MEDLINE (OvidSP) (1946 to May 2014); EMBASE (OvidSP) (1980 to May 2014); BIOSIS (Web of Science) (inception to May 2014); Web of Science Core Collection, including the Conference Proceedings Citation Index (ISI Web of Science) (inception to May 2014); PsycINFO (OvidSP) (inception to May 2014), and LILACS (BIREME) (1982 to May 2014). We also searched specialized sources of diagnostic test accuracy studies and reviews, most recently in May 2014: MEDION (Universities of Maastricht and Leuven, www.mediondatabase.nl), DARE (Database of Abstracts of Reviews of Effects, via the Cochrane Library), HTA Database (Health Technology Assessment Database, via the Cochrane Library), and ARIF (University of Birmingham, UK, www.arif.bham.ac.uk). No language or date restrictions were applied to the electronic searches and methodological filters were not used as a method to restrict the search overall so as to maximize sensitivity. We also checked reference lists of relevant studies and reviews, tracked citations in Scopus and Science Citation Index, used searches of known relevant studies in PubMed to track related articles, and contacted research groups conducting work on MMSE for dementia diagnosis to try to locate possibly relevant but unpublished data.

Selection criteria: We considered longitudinal studies in which results of the MMSE administered to MCI participants at baseline were obtained and the reference standard was obtained by follow-up over time. We included participants recruited and clinically classified as individuals with MCI under Petersen and revised Petersen criteria, Matthews criteria, or a Clinical Dementia Rating = 0.5. We used acceptable and commonly used reference standards for dementia in general, Alzheimer's dementia, Lewy body dementia, vascular dementia and frontotemporal dementia.

Data collection and analysis: We screened all titles generated by the electronic database searches. Two review authors independently assessed the abstracts of all potentially relevant studies. We assessed the identified full papers for eligibility and extracted data to create two by two tables for dementia in general and other dementias. Two authors independently performed quality assessment using the QUADAS-2 tool. Due to high heterogeneity and scarcity of data, we derived estimates of sensitivity at fixed values of specificity from the model we fitted to produce the summary receiver operating characteristic curve.

Main results: In this review, we included 11 heterogeneous studies with a total number of 1569 MCI patients followed for conversion to dementia. Four studies assessed the role of baseline scores of the MMSE in conversion from MCI to all-cause dementia and eight studies assessed this test in conversion from MCI to Alzheimer´s disease dementia. Only one study provided information about the MMSE and conversion from MCI to vascular dementia. For conversion from MCI to dementia in general, the accuracy of baseline MMSE scores ranged from sensitivities of 23% to 76% and specificities from 40% to 94%. In relationship to conversion from MCI to Alzheimer's disease dementia, the accuracy of baseline MMSE scores ranged from sensitivities of 27% to 89% and specificities from 32% to 90%. Only one study provided information about conversion from MCI to vascular dementia, presenting a sensitivity of 36% and a specificity of 80% with an incidence of vascular dementia of 6.2%. Although we had planned to explore possible sources of heterogeneity, this was not undertaken due to the scarcity of studies included in our analysis.

Authors' conclusions: Our review did not find evidence supporting a substantial role of MMSE as a stand-alone single-administration test in the identification of MCI patients who could develop dementia. Clinicians could prefer to request additional and extensive tests to be sure about the management of these patients. An important aspect to assess in future updates is if conversion to dementia from MCI stages could be predicted better by MMSE changes over time instead of single measurements. It is also important to assess if a set of tests, rather than an isolated one, may be more successful in predicting conversion from MCI to dementia.

PubMed Disclaimer

Conflict of interest statement

None known

Figures

1
1
Study flow diagram.
2
2
Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies.
3
3
Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study.
4
4
Forest plot of 1 MMSE conversion to all‐cause dementia.
5
5
Baseline MMSE scores ‐ conversion from MCI to all‐cause dementia.
6
6
Forest plot of 2 MMSE conversion to ADD.
7
7
MMSE scores conversion from MCI to ADD.
1
1. Test
MMSE Conversion to All‐cause Dementia
2
2. Test
MMSE Conversion to AD dementia
3
3. Test
MMSE Conversion to Vascular Dementia
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Buchhave 2008 {published data only}
    1. Buchhave P, Stomrud E, Warkentin S, Blennow K, Minthon L, Hansson O. Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 2008;25(6):544-52. [PMID: ] - PubMed
Chopard 2009 {published data only}
    1. Chopard G, Vanholsbeeck G, Tio G, Pitard A, Binetruy M, Rumbach L, et al. Rapid screening of cognitive change in patients with questionable dementia using the Memory Impairment Screen and the Isaacs Set Test. Journal of the American Geriatrics Society 2009;57(4):703-8. [PMID: ] - PubMed
Conde‐Sala 2012 {published data only}
    1. Conde-Sala JL, Garre-Olmo J, Vilalta-Franch J, Llinas-Regla J, Turro-Garriga O, Lozano-Gallego M, et al. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up. International Psychogeriatrics 2012;24(6):948-58. [PMID: ] - PubMed
Devanand 2008 {published data only}
    1. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biological Psychiatry 2008;64(10):871-9. [PMID: ] - PMC - PubMed
    1. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007;68(11):828-36. [PMID: ] - PubMed
Meguro 2007a {published data only}
    1. Meguro K, Ishii H, Kasuya M, Akanuma K, Meguro M, Kasai M, et al. Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project. Journal of the Neurological Sciences. 2007;260(1-2):175-82. [PMID: ] - PubMed
    1. Nakata E, Kasai M, Kasuya M, Akanuma K, Meguro M, Ishii H, et al. Combined memory and executive function tests can screen mild cognitive impairment and converters to dementia in a community: the Osaki-Tajiri project. Neuroepidemiology 2009;33(2):103-10. [PMID: ] - PubMed
Meguro 2007b {published data only}
    1. Meguro K, Ishii H, Kasuya M, Akanuma K, Meguro M, Kasai M, et al. Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project. Journal of the Neurological Sciences. 2007;260(1-2):175-82. [PMID: ] - PubMed
Modrego 2005 {published data only}
    1. Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. American Journal of Psychiatry 2005;162(4):667-75. [PMID: ] - PubMed
Modrego 2013 {published data only}
    1. Modrego PJ, Gazulla J. The predictive value of the memory impairment screen in patients with subjective memory complaints: a prospective study. The Primary Care Companion for CNS Disorders 2013;15(1). [2155-7772: (Print)] - PMC - PubMed
Palmqvist 2012 {published data only}
    1. Palmquist S, Hertze J, Minthon L, Wattmo C, Zetterberg H, Blennow K, et al. Comparison of brief cognitive tests and CSB biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study. PLoS One 2012;7(6):e38639. [PMID: ] - PMC - PubMed
Pozueta 2011 {published data only}
    1. Pozueta A, Rodriguez-Rodriguez E, Vazquez-Higuera J L, Mateo I, Sanchez-Juan P, Gonzalez-Perez S, et al. Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test. BMC Neurology 2011;11:78. [PMID: 21702929] - PMC - PubMed
Xu 2002 {published data only}
    1. Xu G, Meyer JS, Thornby J, Chowdhury M, Quach M. Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes. International Journal of Geriatric Psychiatry. 2002;17(11):1027-33. [PMID: ] - PubMed

References to studies excluded from this review

Aevarsson 2000 {published data only}
    1. Aevarsson O, Skoog I. A longitudinal population study of the mini-mental state examination in the very old: relation to dementia and education. Dementia and Geriatric Cognitive Disorders 2000;11(3):166-75. [PMID: ] - PubMed
Apostolova 2006 {published data only}
    1. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Archives of Neurology 2006;63(5):693-9. [PMID: ] - PubMed
Armas 2009 {published data only}
    1. Armas J. Clinical and neuropsychological risk factors to conversion from mild cognitive impairment to Alzheimer disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2009;5(4):P382.
Brodaty 2011 {published data only}
    1. Brodaty H, Woodward M, Boundy K, Ames D, Balshaw R. Patients in australian memory clinics: baseline characteristics and predictors of decline at six months. International Psychogeriatrics 2011;23(7):1086-96. [PMID: ] - PubMed
Bruck 2013 {published data only}
    1. Bruck A, Virta JR, Koivunen J, Koikkalainen J, Scheinin NM, Helenius H, et al. [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment. European Journal of Nuclear Medicine and Molecular Imaging 2013;40(10):1567-72. [1619-7089: (Electronic)] - PubMed
Chan 2011 {published data only}
    1. Chan WC, Lam LC, Tam CW, Lui VW, Leung GT, Lee AT, et al. Neuropsychiatric symptoms are associated with increased risks of progression to dementia: A 2-year prospective study of 321 Chinese older persons with mild cognitive impairment. Age and Ageing 2011;40(1):30-5. [PMID: ] - PubMed
Chilovi 2011 {published data only}
    1. Chilovi BV, Caratozzolo S, Mombelli G, Zanetti M, Rozzini L, Padovani A. Does reversible mci exist? Alzheimer's & Dementia 2011;7(4):S548.
Choi 2013 {published data only}
    1. Choi HJ, Lee DY, Seo EH, Sohn BK, Choe YM, Woo JI. Pib-negative amnestic mild cognitive impairment related with low plasma apolipoprotein a1 level. Alzheimer's & Dementia 2013;9(4):P698.
Cruz 2012 {published data only}
    1. Cruz DM, Allen CM, Malmstrom TK, Tumosa N, Morley JE. Does the veterans affairs saint louis university mental status (SLUMS) exam predict the course of cognitive impairment? Journal of the American Geriatrics Society 2012;60:S180.
Devanand 2010 {published data only}
    1. Devanand DP, Van Heertum RI, Kegeles LS, Liu X, Jin ZH, Pradhaban G, et al. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease. American Journal of Geriatric Psychiatry 2010;18(11):959-72. [PMID: ] - PMC - PubMed
Devier 2009 {published data only}
    1. Devier DJ, Pelton GH, Tabert MH, Liu X, Cuasay K, Eisenstadt R, et al. The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease. International Journal of Geriatric Psychiatry 2009;24(12):1335-42. [PMID: ] - PMC - PubMed
Devier 2010 {published data only}
    1. Devier DJ, Villemarette-Pittman N, Brown P, Pelton G, Stern Y, Sano M, et al. Predictive utility of type and duration of symptoms at initial presentation in patients with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders 2010;30(3):238-44. [PMID: ] - PMC - PubMed
Ehrensperger 2010 {published data only}
    1. Ehrensperger MM, Berres M, Taylor KI, Monsch AU. Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer's disease. International Psychogeriatrics 2010;22(1):91-100. [PMID: ] - PubMed
Ewers 2007 {published data only}
    1. Ewers M, Buerger K, Teipel SJ, Scheltens P, Schroder J, Zinkowski RP, et al. Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology 2007;69(24):2205-12. [PMID: ] - PubMed
Hampel 2004 {published data only}
    1. Hampel H, Teipel SJ, Fuchsberger T, Andreasen N, Wiltfang J, Otto M, et al. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Molecular Psychiatry 2004;9(7):705-10. [PMID: ] - PubMed
Ito 2013 {published data only}
    1. Ito K, Mori E, Fukuyama H, Ishii K, Washimi Y, Asada T, et al. Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study. Annals of Nuclear Medicine 2013;27(10):898-906. [1864-6433: (Electronic)] - PMC - PubMed
Koepsell 2012 {published data only}
    1. Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology 2012;79(15):1591-8. [PMID: ] - PMC - PubMed
Korf 2004 {published data only}
    1. Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004;63(1):94-100. [PMID: ] - PubMed
Kruczyk 2012 {published data only}
    1. Kruczyk M, Zetterberg H, Hansson O, Rolstad S, Minthon L, Wallin A, et al. Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment. Journal of Neural Transmission 2012;119(7):821-31. [PMID: ] - PubMed
Li 2011 {published data only}
    1. Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011;76(17):1485-91. [PMID: ] - PubMed
Luck 2012 {published data only}
    1. Luck T, Luppa M, Wiese B, Breitner J, Scherer M, Maier W, et al. Mild cognitive impairment: Determinant patterns of short and long time to incident dementia. Alzheimer's & Dementia 2012;8(4):P151-2.
Madureira 2010 {published data only}
    1. Madureira S, Verdelho A, Moleiro C, Ferro JM, Erkinjuntti T, Jokinen H, et al. Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study. Dementia and Geriatric Cognitive Disorders 2010;29(4):325-34. [PMID: ] - PubMed
Mauri 2012 {published data only}
    1. Mauri M, Sinforiani E, Corbetta S, Zucchella C, Giarracca V, Bono G. Progression to dementia of a population with aMCI: Clinical variables associated to conversion. Journal of Alzheimer's Disease 2011 Suppl 1:S66.
    1. Mauri M, Sinforiani E, Zucchella C, Cuzzoni MG, Bono G. Progression to dementia in a population with amnestic mild cognitive impairment: clinical variables associated with conversion. Functional Neurology 2012;27(1):49-54. [PMID: ] - PMC - PubMed
Meyer 2002 {published data only}
    1. Meyer J, Xu G, Thornby J, Chowdhury M, Quach M. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. Journal of the Neurological Sciences 2002;201(1-2):19-25. [PMID: ] - PubMed
Ott 2013 {published data only}
    1. Ott B, Grace J, Frakey L, Kelley P, Tremont G. Prediction of functional decline and conversion from mild cognitive impairment with the telephone-administered Minnesota Cognitive Acuity Screen. Alzheimer's & Dementia 2013;9(4):P449.
Ouchi 2012 {published data only}
    1. Ouchi Y, Akanuma K, Meguro M, Kasai M, Ishii H, Meguro K. Impaired instrumental activities of daily living affect conversion from mild cognitive impairment to dementia: the Osaki-Tajiri Project. Psychogeriatrics 2012;12(1):34-42. [PMID: ] - PubMed
Paajanen 2014 {published data only}
    1. Paajanen T, Hanninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T, et al. Cerad memory composite score is an accurate neuropsychological predictor of progression to Alzheimer's disease: AddNeuroMed study. Alzheimer's & Dementia 2011;7(4):S259.
    1. Paajanen T, Hanninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T, et al. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study. Journal of Alzheimer's Disease 2014;39(3):679-90. [1875-8908: (Electronic)] - PubMed
Rosenberg 2013 {published data only}
    1. Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The Association of Neuropsychiatric Symptoms in MCI with Incident Dementia and Alzheimer Disease. American Journal of Geriatric Psychiatry 2013;21(7):685-95. [PMID: ] - PMC - PubMed
Serrano 2007 {published data only}
    1. Serrano CM, Taragano F, Allegri RF, Krupitzki H, Martelli M, Feldman M, et al. Conversion predictors factors in mild cognitive impairment [Factores predictores de conversion en deterioro cognitivo leve (cohorte de seguimiento en CEMIC)]. Revista Neurologica Argentina 2007;32(2):75-93.
Tardif 2013 {published data only}
    1. Tardif M, Roy M, Remi B, Laforce R, Verret L, Fortin M-P, et al. Months backward test as a reliable predictor of cognitive decline in mild Alzheimer's disease. Alzheimer's & Dementia 2013;9(4):P741-2.
Van Rossum 2011 {published data only}
    1. Van Rossum I, Burns L, Scheltens P, Soininen H, Wahlund LO, Hampel H, et al. High csf tau predicts rapid decline to Alzheimer's type dementia in mci subjects with abnormal CSF As1-42. Alzheimer's & Dementia 2011;7(4):S548.
van Rossum 2012 {published data only}
    1. Rossum IA, Visser PJ, Knol DL, Flier WM, Teunissen CE, Barkhof F, et al. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. Journal of Alzheimer's Disease 2012;29(2):319-27. - PubMed
Waldorff 2012 {published data only}
    1. Waldorff FB, Siersma V, Vogel A, Waldemar G. Subjective memory complaints in general practice predicts future dementia: a 4-year follow-up study. International Journal of Geriatric Psychiatry 2012;27(11):1180-8. [1099-1166: (Electronic)] - PubMed
Wong 2013 {published data only}
    1. Wong CH, Leung GT, Fung AW, Chan WC, Lam LC. Cognitive predictors for five-year conversion to dementia in community-dwelling Chinese older adults. International Psychogeriatrics / IPA 2013;25(7):1125-34. [1741-203X: (Electronic)] - PubMed
Zhang 2012 {published data only}
    1. Zhang D, Shen D, Alzheimer's Disease Neuroimaging Initiative. Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One 2012;7(3):e33182. [PMID: ] - PMC - PubMed

References to ongoing studies

Hall 2012 {published data only}
    1. Hall J, Plassman BI, Steffens D. Utility of NPI Scores predicting progression of CIND to dementia. American Journal of Geriatric Psychiatry 2012;20(3 Suppl 1):S8-167.

Additional references

Albert 2011
    1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7(3):270-9. - PMC - PubMed
American Psychiatric Association 1994
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington DC: American Psychiatric Association, 1994.
Arevalo‐Rodriguez 2013
    1. Arevalo-Rodriguez I, Pedraza OL, Rodríguez A, Sánchez E, Gich I, Solà I, et al. Alzheimer’s disease dementia guidelines for diagnostic testing: a systematic review. American Journal of Alzheimer's Disease and Other Dementias 2013;28(2):111-9. [PMID: ] - PMC - PubMed
Arevalo‐Rodriguez 2013a
    1. Arevalo-Rodriguez I, Smailagic N, Ciapponi A, Sanchez-Perez E, Giannakou A, Roqué i Figuls M, at al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No: CD010783. [DOI: 10.1002/14651858.CD010783] - DOI - PMC - PubMed
Arevalo‐Rodriguez 2014
    1. Arevalo-Rodriguez I, Segura O, Sola I, Bonfill X, Sanchez E, Alonso-Coello P. Diagnostic tools for alzheimer´s disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews. BMC Neurology 2014;14(1):183. [PMID: ] - PMC - PubMed
Birks 2006
    1. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No: CD005593. [DOI: 10.1002/14651858.CD005593] [PMID: ] - DOI - PMC - PubMed
Bleecker 1988
    1. Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J. Age-specific norms for the Mini-Mental State Exam. Neurology 1988;38(10):1565-8. [PMID: ] - PubMed
Boustani 2003
    1. Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2003;138(11):927-37. [PMID: ] - PubMed
Brayne 1990
    1. Brayne C, Calloway P. The association of education and socioeconomic status with the Mini Mental State Examination and the clinical diagnosis of dementia in elderly people. Age and Ageing 1990;19(2):91-6. [PMID: ] - PubMed
Brayne 2011
    1. Brayne C, Stephan BC, Matthews FE. A European perspective on population studies of dementia. Alzheimer's & Dementia 2011;7(1):3-9. [PMID: 21255739] - PubMed
Bruscoli 2004
    1. Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. International Psychogeriatrics 2004;16(2):129-40. [PMID: ] - PubMed
Chan 2014
    1. Chan Calvin CH, Fage Bruce A, Smailagic N, Gill Sudeep S, Herrmann N, Nikolaou V, et al. Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No: CD011414. [DOI: 10.1002/14651858.CD011414] [CD011414] - DOI - PMC - PubMed
Clare 2003
    1. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No: CD003260. [DOI: 10.1002/14651858.CD003260] [PMID: ] - DOI - PubMed
Crum 1993
    1. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. Journal of the American Medical Association 1993;269(18):2386-91. [PMID: ] - PubMed
Davis 2013
    1. Davis Daniel HJ, Creavin Sam T, Noel-Storr A, Quinn Terry J, Smailagic N, Hyde C, et al. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No: CD010460. [DOI: 10.1002/14651858.CD010460] [CD010460] - DOI - PMC - PubMed
Davis 2013a
    1. Davis DHJ, Creavin ST, Yip JLY, Noel-Storr AH, Brayne C, Cullum S. The Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementia disorders. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No: CD010775. [DOI: 10.1002/14651858.CD010775] [CD010775] - DOI - PMC - PubMed
de Silva 2010
    1. Silva V, Hanwella R. Why are we copyrighting science? BMJ 2010;341:c4738. [PMID: 20847026] - PubMed
Diniz 2007
    1. Diniz BS, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. Mini-Mental State Examination performance in mild cognitive impairment subtypes. International Psychogeriatrics 2007;19(4):647-56. [PMID: ] - PubMed
Dubois 2010
    1. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurology 2010;9(11):1118-27. [PMID: ] - PubMed
Fage 2013
    1. Fage BA, Seitz DP, Gill SS, Herrmann N, Smailagic N, Chan CCH, et al. Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No: CD010860. [DOI: 10.1002/14651858.CD010860] [CD010860] - DOI - PubMed
Farina 2012
    1. Farina N, Isaac MGEKN, Clark Annalie R, Rusted J, Tabet N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No: CD002854. [DOI: 10.1002/14651858.CD002854.pub3] [CD002854] - DOI - PMC - PubMed
Feldman 2008
    1. Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, et al. Diagnosis and treatment of dementia: 2. Diagnosis. Canadian Medical Association Journal 2008;178(7):825-36. [PMID: ] - PMC - PubMed
Ferri 2005
    1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366(9503):2112-7. [PMID: ] - PMC - PubMed
Folstein 1975
    1. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189-98. [PMID: ] - PubMed
Glanville 2012
    1. Glanville J, Cikalo M, Crawford F, Dozier M, McIntosh H. Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation. Research Synthesis Methods 2012;3(3):202-13. [DOI: DOI: 10.1002/jrsm.1046] - PubMed
Goetz 2008
    1. Goetz CG, Emre M, Dubois B. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Annals of Neurology 2008;64 Suppl 2:S81-92. [PMID: ] - PubMed
Harbord 2007
    1. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007;8(2):239-51. [PMID: ] - PubMed
Hort 2010
    1. Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. European Journal of Neurology 2010;17(10):1236-48. [PMID: ] - PubMed
Jack 2011
    1. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7(3):257-62. [PMID: ] - PMC - PubMed
Kokkinou 2014
    1. Kokkinou M, Smailagic N, Noel-Storr AH, Hyde C, Ukoumunne O, Worrall RE, et al. Plasma and cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No: CD010945. [DOI: 10.1002/14651858.CD010945] - DOI - PMC - PubMed
Kulisevsky 2009
    1. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Movement Disorders 2009;24(8):1103-10. [PMID: ] - PubMed
Leeflang 2008
    1. Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54(4):729-37. [PMID: ] - PubMed
Lund and Manchester Groups 1994
    1. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery and Psychiatry 1994;57:416-8. [PMID: ] - PMC - PubMed
Matthews 2008
    1. Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? Journal of the American Geriatrics Society 2008;56(8):1424-33. [PMID: ] - PubMed
Matthews 2009
    1. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine 2009;6(11):e1000180. [PMID: ] - PMC - PubMed
McKeith 1996
    1. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47(5):1113-24. [PMID: ] - PubMed
McKeith 2005
    1. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65(12):1863-72. [PMID: ] - PubMed
McKhann 1984
    1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939-44. [PMID: ] - PubMed
McKhann 2011
    1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7(3):263-9. [PMID: ] - PMC - PubMed
McShane 2006
    1. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No: CD003154. [DOI: 10.1002/14651858.CD003154.pub5] [PMID: ] - DOI - PubMed
Mitchell 2008
    1. Mitchell AJ, Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. Journal of Neurology, Neurosurgery and Psychiatry 2008;79(12):1386-91. - PubMed
Mitchell 2009
    1. Mitchell AJ. A meta-analysis of the accuracy of the Mini-Mental State Examination in the detection of dementia and mild cognitive impairment. Journal of Psychiatric Research 2009;43(4):411-31. [PMID: ] - PubMed
Morris 1993
    1. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43(11):2412-4. [PMID: ] - PubMed
Moyer 2014
    1. Moyer VA. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine 2014;160(11):791-7. [PMID: ] - PubMed
MRC CFAS 2001
    1. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357(0140-6736 (Print)):169-75. [PMID: ] - PubMed
Nieuwenhuis‐Mark 2010
    1. Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose? Journal of Geriatric Psychiatry and Neurology 2010;23(3):151-7. [PMID: ] - PubMed
Petersen 1999
    1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999;56(3):303-8. [PMID: ] - PubMed
Petersen 2001
    1. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56(9):1133-42. - PubMed
Petersen 2004
    1. Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004;256(3):183-94. [PMID: ] - PubMed
Petersen 2011
    1. Petersen RC. Clinical practice: mild cognitive impairment. The New England Journal of Medicine 2011;364(23):2227-34. - PubMed
Plassman 2008
    1. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of cognitive impairment without dementia in the United States. Annals of Internal Medicine 2008;148(6):427-34. - PMC - PubMed
Prince 2013
    1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's & Dementia 2013;9(1):63-75.e2. [PMID: ] - PubMed
Reitsma 2005
    1. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982-90. [PMID: ] - PubMed
Ritchie 2014
    1. Ritchie C, Smailagic N, Noel-Storr Anna H, Takwoingi Y, Flicker L, Mason Sam E, et al. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No: CD008782. [DOI: 10.1002/14651858.CD008782.pub4] - DOI - PMC - PubMed
Roman 1993
    1. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43(2):250-60. [PMID: ] - PubMed
Russ 2012
    1. Russ TC, Morling JR. Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No: CD009132. [DOI: 10.1002/14651858.CD009132.pub2] [CD009132] - DOI - PMC - PubMed
Savva 2009
    1. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. The New England Journal of Medicine 2009;360(22):2302-9. [PMID: ] - PubMed
Scheltens 2011
    1. Scheltens P, Rockwood K. How golden is the gold standard of neuropathology in dementia? Alzheimer's & Dementia 2011;7(4):486-9. [PMID: ] - PubMed
Seitz 2014
    1. Seitz DP, Fage BA, Chan CCH, Gill SS, Herrmann N, Smailagic N, et al. Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No: CD011415. [DOI: 10.1002/14651858.CD011415] [CD011415] - DOI - PMC - PubMed
Shiroky 2007
    1. Shiroky JS, Schipper HM, Bergman H, Chertkow H. Can you have dementia with an MMSE score of 30? American Journal of Alzheimer's Disease and Other Dementias 2007;22(5):406-15. [PMID: ] - PMC - PubMed
Sperling 2011
    1. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7(3):280-92. [1552-5279: (Electronic)] - PMC - PubMed
Stephan 2007
    1. Stephan BC, Matthews FE, McKeith IG, Bond J, Brayne C. Early cognitive change in the general population: how do different definitions work? Journal of the American Geriatrics Society 2007;55(10):1534-40. - PubMed
Tombaugh 1992
    1. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. Journal of the American Geriatrics Society 1992;40(9):922-35. [PMID: ] - PubMed
Trenkle 2007
    1. Trenkle DL, Shankle WR, Azen SP. Detecting cognitive impairment in primary care: performance assessment of three screening instruments. Journal of Alzheimer's Disease 2007;11(3):323-35. [PMID: ] - PubMed
Vacante 2013
    1. Vacante M, Smailagic N, Sachpekidis C, Hyde C, Martin S, Ukoumunne O. The accuracy of 18FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCI. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No: CD010632. [DOI: 10.1002/14651858.CD010632] - DOI - PMC - PubMed
Whiting 2011
    1. Whiting P, Westwood M, Beynon R, Burke M, Sterne JA, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64(6):602-7. [PMID: ] - PubMed
Whiting 2011a
    1. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36. [PMID: ] - PubMed
Wimo 2010
    1. Wimo A, Winblad B, Jonsson L. The worldwide societal costs of dementia: estimates for 2009. Alzheimer's & Dementia 2010;6(2):98-103. [PMID: 20298969 ] - PubMed
Winblad 2004
    1. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 2004;256(3):240-6. [PMID: ] - PubMed
Yue 2012
    1. Yue J, Dong BR, Lin X, Yang M, Wu HM, Wu T. Huperzine A for mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No: CD008827. [DOI: 10.1002/14651858.CD008827.pub2] [CD008827] - DOI - PMC - PubMed
Zhang 2014
    1. Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, Feng J. 11C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No: CD010386. [DOI: 10.1002/14651858.CD010386.pub2] - DOI - PMC - PubMed

Publication types

MeSH terms